Payment; Reports. All royalty payments due to either Party under this Agreement shall be paid in United States dollars within [ * ] after the end of each calendar quarter [ * ] for royalties due from sublicensees), and all other payments will be due within [ * ] of receipt of billing unless otherwise specifically provided herein. Each payment of royalties shall be accompanied by a report of Net Sales in sufficient detail to permit confirmation of the accuracy of the royalty payment made.
Appears in 3 contracts
Sources: Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc), Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc), Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc)
Payment; Reports. All royalty payments due to either Party under this Agreement shall be paid in United States dollars within [ * ] after of the end of each calendar quarter [ * ] for royalties due from sublicensees)quarter, and all other payments will be due within [ * ] of receipt of billing unless otherwise specifically provided herein. Each payment of royalties shall be accompanied by a report of Net Sales in sufficient detail to permit confirmation of the accuracy of the royalty payment made.
Appears in 3 contracts
Sources: Research Collaboration and License Agreement (Tularik Inc), Research Collaboration and License Agreement (Tularik Inc), Research Collaboration and License Agreement (Tularik Inc)
Payment; Reports. All royalty payments due to either Party under this Agreement shall be paid in United States dollars within [ * [*] after the end of each calendar quarter [ * [*] for royalties due from sublicensees), and all other payments will be due within [ * [*] of receipt of billing unless otherwise specifically provided herein. Each payment of royalties shall be accompanied by a report of Net Sales in sufficient detail to permit confirmation of the accuracy of the royalty payment made.
Appears in 1 contract
Sources: Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc)